When the 102-patient phase 2b/3 trial has completed - expected by Oct 28 - approx how many additional days is estimated for it to take the DMC to review the data and submit a recommendation to the FDA?
Anyone know, perhaps based on similar processes/trials with other drugs?
Gee Gee, can you please repost this message. I can then stickie it. A message has to be less than 48 hours old to stickie. Mods have only 1 stickie available. I have removed the one I had, and now await this one.